meta-analysis | Q815382 |
scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1192/BJP.167.6.786 |
P698 | PubMed publication ID | 8829748 |
P2093 | author name string | Lawrie SM | |
Geddes JR | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | schizophrenia | Q41112 |
P1104 | number of pages | 8 | |
P304 | page(s) | 786-793 | |
P577 | publication date | 1995-12-01 | |
P1433 | published in | British Journal of Psychiatry | Q4035428 |
P1476 | title | Obstetric complications and schizophrenia: a meta-analysis | |
P478 | volume | 167 |
Q30478069 | A classification of sociomedical health indicators: perspectives for health administrators and health planners |
Q37399148 | A comparison study of early non-psychotic deviant behavior in Afrikaner and US patients with schizophrenia or schizoaffective disorder |
Q35236431 | A plausible model of schizophrenia must incorporate psychological and social, as well as neuro developmental, risk factors. |
Q40838877 | Adverse pregnancy outcome in schizophrenic women: occurrence and risk factors |
Q48284766 | Alterations in prefrontal glutamatergic and noradrenergic systems following MK-801 administration in rats prenatally exposed to methylazoxymethanol at gestational day 17. |
Q36123856 | Are obstetrical, perinatal, and infantile difficulties associated with pediatric bipolar disorder? |
Q98286217 | Asphyxia at birth affects brain structure in patients on the schizophrenia-bipolar disorder spectrum and healthy participants |
Q33744339 | Association of prenatal and perinatal complications with subsequent bipolar disorder and schizophrenia |
Q39586676 | Associations between childhood living circumstances and schizophrenia: a population-based cohort study. |
Q30367735 | Biomarkers of bipolar disorder: specific or shared with schizophrenia? |
Q34335880 | Childhood determinants of adult psychiatric disorder |
Q35068141 | Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies |
Q52206321 | Childhood-onset schizophrenia and obstetric complications: a case--control study. |
Q30584905 | Childhood-onset schizophrenia: rare but worth studying |
Q40297794 | Comparing cohort incidence of schizophrenia with that of bipolar disorder and affective psychosis in individuals born in Stockholm County 1955-1967. |
Q30474963 | Contribution of nonprimate animal models in understanding the etiology of schizophrenia |
Q51749483 | Coping as a predictor of treatment outcome in people at clinical high risk of psychosis. |
Q73081300 | Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia |
Q36059857 | Cortical circuit dysfunction and cognitive deficits in schizophrenia--implications for preemptive interventions |
Q48364671 | Course of psychopathology, cognition and neurobiological abnormality in schizophrenia: developmental origins and amelioration by antipsychotics? |
Q35238138 | Cumulative biomedical risk and social cognition in the second year of life: prediction and moderation by responsive parenting |
Q91752155 | Deep hypothermia reverses behavioral and histological alterations in a rat model of perinatal asphyxia |
Q38153346 | Development of liability syndromes for schizophrenia: where did they come from and where are they going? |
Q37850311 | Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia? |
Q34389131 | Does consanguinity increase the risk of schizophrenia? Study based on primary health care centre visits |
Q52171892 | Early cerebro-craniofacial dysmorphogenesis in schizophrenia: a lifetime trajectory model from neurodevelopmental basis to 'neuroprogressive' process. |
Q37196812 | Early detection and intervention of psychosis. A review |
Q52185497 | Early developmental differences between DSM-III-R schizophrenics treated with clozapine and typical neuroleptics. |
Q96133509 | Early magnetic resonance imaging biomarkers of schizophrenia spectrum disorders: Toward a fetal imaging perspective |
Q36947280 | Effect of Rhesus D incompatibility on schizophrenia depends on offspring sex. |
Q33949532 | Effect of social class at birth on risk and presentation of schizophrenia: case-control study |
Q33745684 | Epidemiology and natural history of schizophrenia |
Q36919282 | Epidemiology of schizophrenia: review of findings and myths |
Q33773196 | Evidence for maternal-fetal genotype incompatibility as a risk factor for schizophrenia |
Q48020725 | Gender differences in schizophrenia |
Q21129106 | Gene x environment interactions in schizophrenia and bipolar disorder: evidence from neuroimaging |
Q33813156 | Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "two hit hypothesis". |
Q37131027 | Genetic risk for schizophrenia, obstetric complications, and adolescent school outcome: evidence for gene-environment interaction |
Q34369197 | Genetics of childhood-onset schizophrenia |
Q47674388 | Increase in first admissions for schizophrenia and other major psychoses in Italy |
Q34247716 | Interneuron dysfunction in psychiatric disorders |
Q47580114 | Low birthweight in schizophrenia: prematurity or poor fetal growth? |
Q73924963 | Main risk factors for schizophrenia: increased familial loading and pre- and peri-natal complications antagonize the protective effect of oestrogen in women |
Q35124178 | Maternal-fetal blood incompatibility and neuromorphologic anomalies in schizophrenia: Preliminary findings |
Q37820987 | Migration and psychotic disorders |
Q48366115 | Mild ventriculomegaly detected in utero with ultrasound: clinical associations and implications for schizophrenia |
Q37151804 | Minor physical anomalies in schizophrenia: a meta-analysis |
Q56091378 | Modeling the role of infections in the etiology of mental illness |
Q35974517 | Neurodevelopment, neuroplasticity, and new genes for schizophrenia |
Q34721989 | Neurodevelopmental impairment, dopamine sensitisation, and social adversity in schizophrenia |
Q74573840 | Obstetric complications and Apgar score in early-onset schizophrenic patients with prominent positive and prominent negative symptoms |
Q92919813 | Obstetric complications and intelligence in patients on the schizophrenia-bipolar spectrum and healthy participants |
Q58793299 | Obstetric complications as a risk factor for first psychotic episodes in childhood and adolescence |
Q51072814 | Obstetric complications in patients with depression--a population-based case-control study. |
Q73363770 | Obstetric complications in schizophrenia, schizoaffective disorder and normal comparison subjects |
Q57517001 | Obstetric complications in women with schizophrenia |
Q28138647 | Obstetric factors, urbanization and psychosis |
Q74666029 | Obstetrical complications and the development of postpartum depressive symptoms: a prospective survey of the MATQUID cohort |
Q34264958 | Partial genetic deletion of neuregulin 1 and adolescent stress interact to alter NMDA receptor binding in the medial prefrontal cortex |
Q35739024 | Perinatal Risks and Childhood Premorbid Indicators of Later Psychosis: Next Steps for Early Psychosocial Interventions |
Q77452914 | Perinatal characteristics and schizophrenia: electrodermal activity as a mediating link in a vulnerability-stress perspective |
Q34112081 | Perinatal factors affecting expression of obsessive compulsive disorder in children and adolescents |
Q35153968 | Postmaturity in a genetic subtype of schizophrenia |
Q42622181 | Premorbid IQ in patients with functional psychosis and their first-degree relatives |
Q90707526 | Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysis |
Q37411253 | Prenatal and perinatal risk factors for schizophrenia, affective psychosis, and reactive psychosis of early onset: case-control study |
Q33353650 | Prenatal and perinatal risk factors of schizophrenia |
Q49061779 | Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain |
Q34075222 | Prenatal expression patterns of genes associated with neuropsychiatric disorders |
Q37768447 | Prevention of schizophrenia |
Q36058891 | Prevention of schizophrenia: can it be achieved? |
Q41535503 | Pro-inflammatory cytokines and their epistatic interactions in genetic susceptibility to schizophrenia |
Q35613754 | Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia? |
Q47559782 | Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: an umbrella review of meta-analyses |
Q73153621 | Risk for obstetric complications and schizophrenia |
Q73874580 | Schizophrenia |
Q77397124 | Schizophrenia |
Q71121006 | Schizophrenia |
Q48306583 | Schizophrenia and bipolar disorder are distinguished mainly by differences in neurodevelopment |
Q33742817 | Schizophrenia and the environment: speculative interventions |
Q30484459 | Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies |
Q36299679 | Schizophrenia, social class and immigrant status: the epidemiological evidence. |
Q22251476 | Schizophrenia, “Just the Facts”: What we know in 2008 |
Q59117302 | Schizophrenia: The Epidemiological Horizon |
Q41463762 | Schizophrenia: a disorder of neurodevelopment? |
Q36478249 | Schizophrenia: an integrative approach to modelling a complex disorder. |
Q33338398 | Schizophrenia: solving the puzzle |
Q35236282 | Schizophrenia: vulnerability versus disease. |
Q51894967 | Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk. |
Q47842022 | The "polyenviromic risk score": Aggregating environmental risk factors predicts conversion to psychosis in familial high-risk subjects. |
Q37419966 | The 22q11.2 deletion syndrome as a window into complex neuropsychiatric disorders over the lifespan. |
Q59052397 | The Concept of Schizophrenia: From Unity to Diversity |
Q22242827 | The dopamine hypothesis of schizophrenia: version III--the final common pathway |
Q48532698 | The dysplastic net hypothesis: an integration of developmental and dysconnectivity theories of schizophrenia |
Q30459929 | The environment and susceptibility to schizophrenia |
Q36550599 | The human hypothalamus in metabolic and episodic disorders. |
Q21129355 | The impact of environmental factors in severe psychiatric disorders |
Q34113063 | The nature of schizophrenia: signposts to prevention |
Q33679792 | The neurodevelopmental basis of schizophrenia: clinical clues from cerebro-craniofacial dysmorphogenesis, and the roots of a lifetime trajectory of disease |
Q36034203 | The neurodevelopmental model of schizophrenia: update 2005. |
Q40862601 | The new epidemiology of schizophrenia |
Q24644325 | The role of obstetric events in schizophrenia |
Q52003853 | The trap of protopathic bias in neuropsychiatric research. |
Q52171886 | Transient birth hypoxia increases behavioral responses to repeated stress in the adult rat. |
Q73521195 | Type of feeding during infancy and later development of schizophrenia |
Q47547157 | What causes psychosis? An umbrella review of risk and protective factors |
Q37798832 | Young Rural People at Risk for Schizophrenia: Time for Mental Health Services to Translate Research Evidence into Best Practice of Care |
Search more.